Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)

被引：0
|
作者：
Lips, Esther H.
Michaut, Magali
Mulder, Lennart
Besselink, Nicolle
Hoogstraat, Marlous L.
Koudijs, Marco J.
Voest, Emile E.
Bernards, Rene
Wesseling, Jelle
Wessels, Lodewyk F. A.
Rodenhuis, Sjoerd
机构：
[1] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands
[3] UMC Utrecht, Dept Med Oncol, Ctr Personalized Canc Treatment, Utrecht, Netherlands
[4] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[5] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1010
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Using next-generation sequencing to predict clinical outcome of triple negative breast cancer
    Thouvenot, B.
    Verdun, S.
    Tomasina, J.
    Hilselberger, B.
    Brulliard, M.
    Bonnard, L.
    Trarbach, M.
    Armand, J.
    Ogier, V.
    Bihain, B. E.
    BREAST, 2015, 24 : S120 - S120
  • [22] Mutational profiling in triple-negative essential thrombocythaemia with targeted next-generation sequencing
    Michail, O.
    Catherwood, M.
    Cuthbert, R.
    Arnold, C.
    McAllister, R.
    McMullin, M. F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 59 - 60
  • [23] Intrinsic subtype and response to neoadjuvant chemotherapy with carboplatin and docetaxel (TCb) in triple-negative breast cancer (TNBC)
    Echavarria Diaz-Guardamino, I.
    Lopez-Tarruella, S.
    Garcia-Saenz, J. A.
    Gomez Moreno, H.
    Moreno, F.
    Jerez, Y.
    Fuentes, H.
    Marquez-Rodas, I.
    Cebollero, M.
    Del Monte-Millan, M.
    Picornell, A.
    Massarrah, T.
    Barnadas, A.
    Prat, A.
    Ballesteros Garcia, A.
    Colomer Bosch, R.
    Pelaez, B.
    Gonzalez-Rivera, M.
    Perou, C. M.
    Martin, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [25] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [26] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [27] Phosphoproteomic portraits of triple-negative breast cancer (TNBC)
    Quintela-Fandino, Miguel
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez, Gonzalo
    Pisano, David G.
    Munoz, Javier
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [29] Next-generation sequencing mutational analysis of triple-negative breast cancer patients from matched FFPE and fresh frozen samples
    Landers, Mark
    Meredith, Rhonda
    Lee, Jerry
    Wang, Yipeng
    Lee, Byung-In
    Monforte, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Next-generation RNA sequencing identifies UHRF1 as a key regulatory protein in triple-negative breast cancer survival
    Solzak, Jeffrey P.
    Atale, Rutuja
    Radovich, Milan
    CANCER RESEARCH, 2013, 73 (08)
12345